DocGo Inc. (DCGO) Insider Trading Activity

NASDAQ$0.8128+0.02 (2.51%)
Market Cap
$77.88M
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
305 of 885
Rank in Industry
12 of 39

DCGO Insider Trading Activity

DCGO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$116,650
6
86
Sells
$15,334
1
14

Related Transactions

Burdiek Michael Jdirector
2
$34,750
0
$0
$34,750
Bienstock LeeChief Executive Officer
1
$23,100
0
$0
$23,100
Klasko Stephen K. M.D.director
1
$22,350
0
$0
$22,350
ROSENBERG NORMANCFO and Treasurer
1
$22,050
0
$0
$22,050
Sugrue StephenChief Compliance Officer
1
$14,400
0
$0
$14,400
Tendler Ely DGeneral Counsel and Secretary
0
$0
1
$15,334
$-15,334

About DocGo Inc.

DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.

Insider Activity of DocGo Inc.

Over the last 12 months, insiders at DocGo Inc. have bought $116,650 and sold $15,334 worth of DocGo Inc. stock.

On average, over the past 5 years, insiders at DocGo Inc. have bought $191,020 and sold $1.41M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Burdiek Michael J (director) — $34,750. Bienstock Lee (Chief Executive Officer) — $23,100. Klasko Stephen K. M.D. (director) — $22,350.

The last purchase of 10,000 shares for transaction amount of $13,300 was made by Burdiek Michael J (director) on 2025‑05‑23.

List of Insider Buy and Sell Transactions, DocGo Inc.

2025-12-15SaleTendler Ely DGeneral Counsel and Secretary
16,850
0.0169%
$0.91
$15,334
-5.71%
2025-05-23PurchaseBurdiek Michael Jdirector
10,000
0.01%
$1.33
$13,300
-4.48%
2025-05-15PurchaseBurdiek Michael Jdirector
15,000
0.0155%
$1.43
$21,450
-6.43%
2025-05-14PurchaseBienstock LeeChief Executive Officer
15,000
0.0166%
$1.54
$23,100
-5.71%
2025-05-14PurchaseROSENBERG NORMANCFO and Treasurer
15,000
0.0159%
$1.47
$22,050
-5.71%
2025-05-14PurchaseSugrue StephenChief Compliance Officer
10,000
0.0104%
$1.44
$14,400
-5.71%
2025-05-14PurchaseKlasko Stephen K. M.D.director
15,000
0.0161%
$1.49
$22,350
-5.71%
2024-12-17SaleLeite Etalvinadirector
16,500
0.0162%
$4.34
$71,610
-64.24%
2024-12-16SaleTendler Ely DGeneral Counsel and Secretary
23,088
0.0226%
$4.44
$102,511
-65.03%
2024-05-14PurchaseBurdiek Michael Jdirector
10,000
0.0077%
$3.40
$34,000
+2.88%
2024-05-13PurchaseBienstock LeeChief Executive Officer
25,000
0.0178%
$3.15
$78,750
+7.44%
2024-05-13PurchaseTendler Ely DGeneral Counsel and Secretary
10,000
0.0071%
$3.13
$31,300
+7.44%
2024-03-15PurchaseKATZ STEVENdirector
13,500
0.0111%
$3.64
$49,140
-3.55%
2024-03-14PurchaseBurdiek Michael Jdirector
10,000
0.0082%
$3.61
$36,100
-0.70%
2024-03-14PurchaseROSENBERG NORMANCFO and Treasurer
10,000
0.0082%
$3.61
$36,100
-0.70%
2023-11-28SaleSugrue StephenChief Compliance Officer
2,859
0.0037%
$5.75
$16,439
-38.64%
2023-10-16SaleBienstock LeeChief Executive Officer
1,667
0.0022%
$5.89
$9,819
-40.83%
2023-10-02SaleTendler Ely DGeneral Counsel and Secretary
10,000
0.012%
$5.29
$52,900
-32.36%
2023-09-15SaleBienstock LeeChief Executive Officer
1,667
0.0024%
$6.32
$10,535
-36.14%
2023-09-15SaleTendler Ely DGeneral Counsel and Secretary
10,000
0.0134%
$5.91
$59,100
-36.14%
Total: 35
*Gray background shows transactions not older than one year

Insider Historical Profitability

2.13%
Bienstock LeeChief Executive Officer
1971079
2.0151%
$1.57M23
+7.44%
ROSENBERG NORMANCFO and Treasurer
871272
0.8907%
$693,706.7720
<0.0001%
Burdiek Michael Jdirector
641560
0.6559%
$510,810.0740
+1.09%
Sugrue StephenChief Compliance Officer
357328
0.3653%
$284,504.5511
Tendler Ely DGeneral Counsel and Secretary
258795
0.2646%
$206,052.5815
+7.44%
Klasko Stephen K. M.D.director
15000
0.0153%
$11,943.0010
Oberholzer Adriaan StephanusSee Remarks
1114384
1.1393%
$887,272.5408
Capone AnthonyChief Executive Officer
404275
0.4133%
$321,883.7603
TRAVERS JAMES Mdirector
391028
0.3998%
$311,336.4902
KATZ STEVENdirector
69534
0.0711%
$55,362.9710
<0.0001%
Leite Etalvinadirector
51411
0.0526%
$40,933.4401
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

DocGo Inc.
(DCGO)
$265,390
6
2.13%
$77.88M
$2,197,800
5
46.80%
$98.57M
$339,600
1
-13.81%
$1.4B

DCGO Institutional Investors: Active Positions

Increased Positions46+30.67%4M+7.36%
Decreased Positions63-42%7M-15.06%
New Positions16New815,056New
Sold Out Positions23Sold Out3MSold Out
Total Postitions133-11.33%46M-7.7%

DCGO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$5,635.006.48%6.35M-112,429-1.74%2025-09-30
Vanguard Group Inc$4,511.005.18%5.08M-236,217-4.44%2025-09-30
Deerfield Management Company, L.P.$4,105.004.72%4.62M-318,857-6.45%2025-09-30
P.A.W. Capital Corp$2,842.003.27%3.2M00%2025-09-30
Knott David M Jr$2,727.003.13%3.07M00%2025-09-30
S Squared Technology, Llc$2,154.002.48%2.43M-452,488-15.72%2025-09-30
Geode Capital Management, Llc$1,941.002.23%2.19M+30,000+1.39%2025-09-30
Jefferies Financial Group Inc.$1,904.002.19%2.14M00%2025-09-30
State Street Corp$1,714.001.97%1.93M+12,768+0.67%2025-09-30
Moore Capital Management, Lp$1,301.001.5%1.47M00%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.